ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering – Yahoo Finance

ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering Yahoo Finance

ContraVir Pharmaceuticals, Inc. (“ContraVir,” the “Company,” “we,” “our” or “us”) (CTRV), a biopharmaceutical company focused on the development of …